H. pylori Treatment Recommendations
Bismuth quadruple therapy for 14 days is the preferred first-line treatment for H. pylori infection when antibiotic susceptibility is unknown. 1, 2
First-Line Treatment Options
Preferred Regimen: Bismuth Quadruple Therapy (14 days)
- PPI (twice daily)
- Bismuth subsalicylate/subcitrate
- Tetracycline
- Metronidazole
- Expected eradication rate: 85% 1
Alternative First-Line Options:
In areas with low clarithromycin resistance (<15%):
For patients with penicillin allergy:
- Bismuth quadruple therapy (as above) 1
FDA-approved regimens 4:
- Triple therapy: 1g amoxicillin, 500mg clarithromycin, and 30mg lansoprazole, all twice daily for 14 days
- Dual therapy: 1g amoxicillin and 30mg lansoprazole, each three times daily for 14 days (for patients allergic/intolerant to clarithromycin)
Second-Line Treatment Options
If first-line therapy fails, recommended options include:
Levofloxacin-based triple therapy (14 days):
Bismuth quadruple therapy (14 days):
Third-Line Treatment Options
For patients with multiple treatment failures:
Antimicrobial susceptibility testing (AST) should guide therapy when available 3, 2
If AST unavailable:
Important Considerations
Administration Guidelines
- Take medications at the start of meals to minimize gastrointestinal intolerance 4
- Patient counseling is essential:
- Warn about darkening of stool from bismuth
- Advise avoiding alcohol while taking metronidazole (disulfiram-like reaction)
- Stress importance of completing full course 1
Testing for Eradication
- Test for eradication at least 4 weeks after completing treatment 1
- Use urea breath test or monoclonal stool antigen test
- Stop PPI at least 2 weeks before testing 1
Special Populations
- Renal impairment: Adjust amoxicillin dosage for severe renal impairment (GFR <30 mL/min) 4
- Pregnancy: Avoid invasive diagnostic procedures unless absolutely necessary 1
Treatment Pitfalls to Avoid
- Don't use clarithromycin-containing regimens in areas with high clarithromycin resistance (≥15%) without susceptibility testing 7
- Don't forget to test for eradication after treatment completion
- Don't use antibiotics previously failed without susceptibility testing
- Poor compliance significantly reduces eradication rates; patient education is crucial 1
By following these evidence-based recommendations, H. pylori infection can be effectively treated, reducing the risk of complications such as peptic ulcer disease and gastric cancer.